public sectors, and examination of opportunities for enhancing and optimizing collaboration.

•   Identification of potential innovative solutions to the problem.

Day One

8:00 a.m.     Continental Breakfast Available

8:30 a.m.     Opening Remarks

 

GAIL CASSELL, Workshop Co-Chair

Visiting Professor, Department of Global Health and Social

Medicine, Harvard Medical School

Vice President, TB Drug Discovery, Infectious Disease

Research Institute

Vice President, Scientific Affairs and Distinguished Lilly

Research Scholar for Infectious Diseases, Eli Lilly and Company (retired)

 

BARRY BLOOM, Workshop Co-Chair

Distinguished Service Professor, Department of Immunology and Infectious Diseases, Harvard University

Dean of the Harvard School of Public Health (former)

SESSION I: OVERVIEW OF THE BARRIERS IN THE SUPPLY CHAIN FOR MDR TB DRUGS

Session Objectives:

•   Provide an overview of the history and current operational structure of the supply chain for SLDs for MDR TB.

•   Examine barriers preventing the optimal operation of the current supply chain.

•   Discuss implications for access to SLDs as they are approved and become available as new drugs on the market.

9:00 a.m.     Overview, Background, and Session Objectives

 

PETER CEGIELSKI, Session Chair

Team Leader for Drug-Resistant TB

International Research and Programs Branch, Division of Tuberculosis Elimination

U.S. Centers for Disease Control and Prevention



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement